A detailed history of Quantbot Technologies LP transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 19,738 shares of TMDX stock, worth $1.13 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
19,738
Previous 2,812 601.92%
Holding current value
$1.13 Million
Previous $423,000 632.39%
% of portfolio
0.13%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$135.68 - $176.11 $2.3 Million - $2.98 Million
16,926 Added 601.92%
19,738 $3.1 Million
Q2 2024

Aug 09, 2024

BUY
$72.62 - $150.62 $64,123 - $132,997
883 Added 45.78%
2,812 $423,000
Q1 2024

May 06, 2024

BUY
$70.86 - $89.93 $61,506 - $78,059
868 Added 81.81%
1,929 $142,000
Q4 2023

Feb 14, 2024

SELL
$36.74 - $81.08 $1.26 Million - $2.79 Million
-34,393 Reduced 97.01%
1,061 $83,000
Q3 2023

Nov 07, 2023

BUY
$53.47 - $96.07 $610,787 - $1.1 Million
11,423 Added 47.53%
35,454 $1.94 Million
Q2 2023

Aug 08, 2023

BUY
$66.23 - $88.73 $780,719 - $1.05 Million
11,788 Added 96.28%
24,031 $2.02 Million
Q1 2023

May 12, 2023

BUY
$53.63 - $82.33 $319,902 - $491,098
5,965 Added 95.01%
12,243 $927,000
Q4 2022

Feb 13, 2023

SELL
$39.08 - $64.29 $1.12 Million - $1.85 Million
-28,713 Reduced 82.06%
6,278 $387,000
Q3 2022

Nov 07, 2022

BUY
$31.56 - $55.75 $1.1 Million - $1.95 Million
34,991 New
34,991 $1.46 Million
Q1 2022

May 16, 2022

SELL
$12.58 - $26.94 $49,502 - $106,008
-3,935 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$19.16 - $32.68 $19,160 - $32,680
-1,000 Reduced 20.26%
3,935 $75,000
Q3 2021

Nov 09, 2021

BUY
$25.92 - $34.51 $8,683 - $11,560
335 Added 7.28%
4,935 $163,000
Q2 2021

Aug 12, 2021

BUY
$21.63 - $40.07 $99,498 - $184,322
4,600 New
4,600 $152,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $1.82B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.